Operator of a microbiome research firm intended to transform microbiome research, diagnostics and therapeutics. The company delivers a high-throughput low-cost platform for dynamic and real-time analysis and quantification of the human gut microbiome, offering informed precision diagnostics and targeted therapies, enabling patients to improve their lives through novel approaches to lead a healthy life.
NavVis GmbH specializes in indoor spatial intelligence solutions for enterprises, offering advanced tools for mapping and visualizing indoor environments. The company develops the NavVis M6, a mobile mapping system designed for large-scale scanning projects, which captures immersive 360° imagery and point clouds. Its NavVis IndoorViewer integrates these point clouds with detailed images to create digital twins, allowing stakeholders to interact with scanned spaces. The company also provides a software development kit to enhance its offerings. NavVis's solutions support various applications, including CAD/BIM modeling, factory planning, maintenance, and indoor navigation. Its client base includes prominent firms in the automotive, construction, real estate, and insurance sectors. Founded in 2013 and headquartered in Munich, Germany, NavVis also maintains offices in New York and Shanghai.
GoBolt, formerly known as Second Closet Incorporated, provides valet self-storage services that enable customers to store their belongings conveniently and securely. Founded in 2017 and based in Toronto, Canada, the company offers a comprehensive solution where customers can schedule pickups and returns of their items. GoBolt delivers boxes for customers to use for storage, then collects these items to be stored in a climate-controlled warehouse. The service is designed to be user-friendly, allowing clients to pay only for the space they utilize, making it an affordable option for those in need of storage solutions.
iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The company focuses on creating innovative cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. By employing a systematic screening approach of human tumor cells, iOmx has identified several new targets and studied their mechanisms of action. The foundation of its research is based on the principles of cancer immune-checkpoint therapy, which aims to overcome the natural resistance of tumors to immune responses. This resistance is often facilitated by cell surface molecules that activate immune-inhibitory receptors on T cells. By neutralizing these inhibitory interactions, iOmx Therapeutics seeks to reactivate the host immune response, thereby enhancing the effectiveness of cancer treatments.
KEWAZO GmbH develops robotics systems that enable the autonomous transport of materials on the construction site in vertical and horizontal dimensions for large scaffolding companies and industrial service providers. It provides a safe assembly transport of scaffolding parts by delivering parts just-in-time and just-in-place during assembly. The company was founded in 2016 and is based in Gilching, Germany.
AMSilk GmbH, based in Munich, Germany, specializes in producing spider silk proteins and biomaterials for various industrial applications. The company offers a range of products, including BioShield-S1, a non-immunogenic spider silk film used for protective coatings in medical devices, as well as biosteel spider silk fibers. AMSilk also develops over-the-counter wound care products like SanaSilk, designed to protect the skin, and provides spider silk-based solutions for surgical applications. Additionally, the company produces spider silk protein beads and coatings for medical technology, alongside nonwovens for filters, wound dressings, and specialty textiles. Its offerings include both raw materials and semi-finished products such as membranes and films. AMSilk serves multiple sectors, including pharmaceuticals, cosmetics, and technical textiles, and has established a strategic partnership with Gruschwitz Textilwerke AG. The company was founded in 2008.
GoBolt, formerly known as Second Closet Incorporated, provides valet self-storage services that enable customers to store their belongings conveniently and securely. Founded in 2017 and based in Toronto, Canada, the company offers a comprehensive solution where customers can schedule pickups and returns of their items. GoBolt delivers boxes for customers to use for storage, then collects these items to be stored in a climate-controlled warehouse. The service is designed to be user-friendly, allowing clients to pay only for the space they utilize, making it an affordable option for those in need of storage solutions.
Developer of a silicon carbide designed to improve the manufacturing process of the growing power electronics industry. The company uses crystal production which improves the development of key systems for electric vehicles such as inverters and on-board chargers, enabling clients to reduce semiconductor production costs.
wealthpilot GmbH, founded in 2017 and based in Munich, Germany, operates an online platform tailored for investment advisors. The company aims to democratize wealth management, allowing individuals to take control of their financial lives and achieve their financial goals. By integrating user-friendly technology with professional advisory services, wealthpilot provides a Software-as-a-Service platform that automatically analyzes and plans various types of assets. This innovative approach enables financial advisors to deliver personalized, data-driven wealth management while streamlining processes through automation, thereby enhancing their efficiency in managing both new and existing client assets.
Founded in 2014, Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management. Winner of 'Health IT Firm of the Year' at the HealthInvestor Awards 2018 and 'Healthtech Innovators of the Year - Europe' at the Global Health & Pharma Awards 2018, Liva Healthcare is used by public healthcare, private insurance and pharma companies including NHS England and AXA PPP Healthcare. Liva Healthcare’s platform facilitates ongoing personalised health coaching through an intuitive app, building strong bond between coach, GP and patient. Its focus lies on tackling chronic illnesses, such as Type 2 diabetes, obesity and heart disease by driving behaviour change. The app is multilingual across several languages, proven to work efficiently across all socio-economic backgrounds and is capable of engaging groups normally hard to reach. It is based upon nine to 18 months of continuous patient engagement to make new habits and behaviours stick. One coach can manage 500 patients per year simultaneously without the loss of patient outcomes. Implementation time from get-go is normally within weeks and the platform is available as a white-label SaaS platform or as a turn-key solution, dependent on client specifications. Liva Healthcare has offices in Copenhagen, Denmark and London, UK.
German Bionic Systems GmbH specializes in the development and manufacturing of exoskeleton devices tailored for industrial applications. Founded in 2016 and headquartered in Augsburg, Germany, the company also has offices in Berlin, Tokyo, and Singapore. Its flagship product, the German Bionic CRAY X, is an intelligent wearable exoskeleton designed to assist users in various industries during manual handling tasks. This innovative device combines human intelligence with mechanical power, enhancing the strength and endurance of its users while significantly reducing lower back compression forces. By prioritizing ergonomic design and lightweight materials, the exoskeleton offers comfort and usability, aimed at preventing injuries associated with manual labor. As a leader in the robotics sector, German Bionic is committed to advancing human capabilities in the context of Industry 4.0.
Innatera Nanosystems B.V. develops microprocessors that mimic the brain’s mechanisms for processing fast information streams from multiple sensors. The company is based in Delft, the Netherlands.
IQM Finland Oy is a company that specializes in the development and manufacturing of hardware systems for quantum computing. Founded in 2018 and headquartered in Espoo, Finland, IQM focuses on creating scalable quantum processors based on superconducting technology. The company aims to advance quantum computing capabilities, facilitating solutions that can benefit both industry and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has made significant strides in areas such as thermal management, which enhances computational speed and information accuracy. These innovations establish IQM as a key player in the global movement towards practical, large-scale quantum computing solutions.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
KEWAZO GmbH develops robotics systems that enable the autonomous transport of materials on the construction site in vertical and horizontal dimensions for large scaffolding companies and industrial service providers. It provides a safe assembly transport of scaffolding parts by delivering parts just-in-time and just-in-place during assembly. The company was founded in 2016 and is based in Gilching, Germany.
Temedica GmbH, founded in 2016 and based in Munich, Germany, specializes in developing digital solutions that support medical therapies. The company offers an online platform enabling physicians and physiotherapists to create personalized home exercise plans for patients, allowing for effective tracking of their recovery. By focusing on digitization, Temedica aims to improve healthcare delivery, enhancing efficiency, quality, and transparency while addressing the needs of various stakeholders. Through its digital products, the company strives to elevate the quality of patient care and reduce costs within the healthcare system.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
IQM Finland Oy is a company that specializes in the development and manufacturing of hardware systems for quantum computing. Founded in 2018 and headquartered in Espoo, Finland, IQM focuses on creating scalable quantum processors based on superconducting technology. The company aims to advance quantum computing capabilities, facilitating solutions that can benefit both industry and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has made significant strides in areas such as thermal management, which enhances computational speed and information accuracy. These innovations establish IQM as a key player in the global movement towards practical, large-scale quantum computing solutions.
CYNORA GmbH, founded in 2008 and based in Bruchsal, Germany, specializes in the development and manufacture of organic electronics, particularly focusing on organic light-emitting diodes (OLEDs) and organic solar cells. The company is known for its innovative use of Thermally Activated Delayed Fluorescence (TADF) technology, which allows for the efficient conversion of triplet excitons into light, thereby enhancing the performance of OLED devices while reducing power consumption. CYNORA's emitter systems, which are free from iridium, provide high efficiency and stability, addressing the industry's demand for thin, flexible screens with improved image quality. The company collaborates with major manufacturers in Korea and China to showcase the capabilities of its patented materials, contributing significantly to advancements in the AMOLED market. Through their offerings, CYNORA aims to deliver substantial efficiency improvements for display manufacturers, meeting the growing expectations for high-performance OLED products.
Founded in 2014, Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management. Winner of 'Health IT Firm of the Year' at the HealthInvestor Awards 2018 and 'Healthtech Innovators of the Year - Europe' at the Global Health & Pharma Awards 2018, Liva Healthcare is used by public healthcare, private insurance and pharma companies including NHS England and AXA PPP Healthcare. Liva Healthcare’s platform facilitates ongoing personalised health coaching through an intuitive app, building strong bond between coach, GP and patient. Its focus lies on tackling chronic illnesses, such as Type 2 diabetes, obesity and heart disease by driving behaviour change. The app is multilingual across several languages, proven to work efficiently across all socio-economic backgrounds and is capable of engaging groups normally hard to reach. It is based upon nine to 18 months of continuous patient engagement to make new habits and behaviours stick. One coach can manage 500 patients per year simultaneously without the loss of patient outcomes. Implementation time from get-go is normally within weeks and the platform is available as a white-label SaaS platform or as a turn-key solution, dependent on client specifications. Liva Healthcare has offices in Copenhagen, Denmark and London, UK.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
KONUX GmbH, founded in 2014 and based in Munich, Germany, develops Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence analytics. The company specializes in enhancing railway operations, offering a range of services including switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive maintenance. KONUX's solutions enable real-time monitoring of infrastructure conditions and improve operational efficiency, capacity, and reliability in railway and industrial applications. The company has attracted significant investment, raising over $50 million and expanding its presence across Europe and Asia. Recognized by the World Economic Forum as one of the world's most innovative start-ups, KONUX is committed to transforming railway mobility for a sustainable future.
NavVis GmbH specializes in indoor spatial intelligence solutions for enterprises, offering advanced tools for mapping and visualizing indoor environments. The company develops the NavVis M6, a mobile mapping system designed for large-scale scanning projects, which captures immersive 360° imagery and point clouds. Its NavVis IndoorViewer integrates these point clouds with detailed images to create digital twins, allowing stakeholders to interact with scanned spaces. The company also provides a software development kit to enhance its offerings. NavVis's solutions support various applications, including CAD/BIM modeling, factory planning, maintenance, and indoor navigation. Its client base includes prominent firms in the automotive, construction, real estate, and insurance sectors. Founded in 2013 and headquartered in Munich, Germany, NavVis also maintains offices in New York and Shanghai.
GWA Hygiene GmbH is a German company based in Stralsund, founded in 2015, specializing in hygiene monitoring systems for healthcare settings. The company designs and manufactures sensors that monitor hand hygiene standards among hospital personnel, as well as developing a software application that tracks disinfection rates across various wards and professional groups. GWA Hygiene's solutions integrate the Internet of Things (IoT) technology, allowing for the monitoring of both hand and surface disinfection processes. Their sensor technology is installed in disinfectant and soap dispensers, providing real-time data displayed on monitors. Users can choose to store data on an in-house server or utilize the company’s secure cloud server. The accompanying software toolbox enables analysis of hygiene processes and streamlines logistical tasks, such as managing disinfectant supplies and maintaining devices.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
advanceCOR GmbH is a drug development company based in Munich, Germany, specializing in therapeutics and diagnostics for heart and vascular diseases. Founded in 2000, the company focuses on creating personalized treatments and has developed several innovative products. Notable among these is Revacept, a human Fc fusion protein that inhibits the local activation of platelets at vascular injury sites. Additionally, advanceCOR offers COR-2, a recombinant protein that reduces foam cell generation and cholesterol uptake, and COR-3, which targets atherosclerotic plaques while binding to progenitor cells to promote plaque healing. The company’s product pipeline also includes therapies for acute arterial thrombosis, myocardial infarction, stroke, and transient ischemic attack, emphasizing its commitment to addressing serious cardiovascular conditions.
KEWAZO GmbH develops robotics systems that enable the autonomous transport of materials on the construction site in vertical and horizontal dimensions for large scaffolding companies and industrial service providers. It provides a safe assembly transport of scaffolding parts by delivering parts just-in-time and just-in-place during assembly. The company was founded in 2016 and is based in Gilching, Germany.
KONUX GmbH, founded in 2014 and based in Munich, Germany, develops Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence analytics. The company specializes in enhancing railway operations, offering a range of services including switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive maintenance. KONUX's solutions enable real-time monitoring of infrastructure conditions and improve operational efficiency, capacity, and reliability in railway and industrial applications. The company has attracted significant investment, raising over $50 million and expanding its presence across Europe and Asia. Recognized by the World Economic Forum as one of the world's most innovative start-ups, KONUX is committed to transforming railway mobility for a sustainable future.
BioNTech is a biotechnology company focused on developing and commercializing immunotherapies for cancer and infectious diseases. Founded in 2008 and headquartered in Mainz, Germany, the company has pioneered innovative therapies through advanced computational discovery and drug development platforms. BioNTech's oncology pipeline includes various neoantigen-targeted therapies, such as NEO-PV-01 for advanced non-small cell lung cancer and multiple FixVac product candidates for different cancers, including melanoma, prostate cancer, and HPV-positive head and neck cancers. The company also explores mRNA vaccine candidates for infectious diseases and maintains collaborations with prominent pharmaceutical firms. BioNTech Cell & Gene Therapies GmbH, a subsidiary, specializes in developing T cell immunotherapies for cancer treatment.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
Affiris AG is a Vienna-based company that specializes in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer's disease, Parkinson's disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington's disease. By providing innovative treatment options for neurodegenerative diseases, Affiris strives to enhance the quality of life for patients while offering healthcare professionals a higher level of safety and efficacy compared to traditional therapies.
LXP Group GmbH, based in Marienwerder, Germany, specializes in the development of the LX-Process, which effectively cracks 2G biomass for the production of 2G ethanol, biochemicals, and natural lignin. Established in 2009, the company offers a scalable solution that can be adapted for large-scale ethanol manufacturing while also allowing for the economic retrofit of smaller, decentralized biogas plants. The LX-Process addresses significant challenges in bio-processing by eliminating inhibitors that typically arise in conventional 2G pre-treatment methods, thereby enhancing the efficiency and viability of biomass conversion.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
KONUX GmbH, founded in 2014 and based in Munich, Germany, develops Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence analytics. The company specializes in enhancing railway operations, offering a range of services including switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive maintenance. KONUX's solutions enable real-time monitoring of infrastructure conditions and improve operational efficiency, capacity, and reliability in railway and industrial applications. The company has attracted significant investment, raising over $50 million and expanding its presence across Europe and Asia. Recognized by the World Economic Forum as one of the world's most innovative start-ups, KONUX is committed to transforming railway mobility for a sustainable future.
KONUX GmbH, founded in 2014 and based in Munich, Germany, develops Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence analytics. The company specializes in enhancing railway operations, offering a range of services including switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive maintenance. KONUX's solutions enable real-time monitoring of infrastructure conditions and improve operational efficiency, capacity, and reliability in railway and industrial applications. The company has attracted significant investment, raising over $50 million and expanding its presence across Europe and Asia. Recognized by the World Economic Forum as one of the world's most innovative start-ups, KONUX is committed to transforming railway mobility for a sustainable future.
Affiris AG is a Vienna-based company that specializes in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer's disease, Parkinson's disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington's disease. By providing innovative treatment options for neurodegenerative diseases, Affiris strives to enhance the quality of life for patients while offering healthcare professionals a higher level of safety and efficacy compared to traditional therapies.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
KONUX GmbH, founded in 2014 and based in Munich, Germany, develops Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence analytics. The company specializes in enhancing railway operations, offering a range of services including switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive maintenance. KONUX's solutions enable real-time monitoring of infrastructure conditions and improve operational efficiency, capacity, and reliability in railway and industrial applications. The company has attracted significant investment, raising over $50 million and expanding its presence across Europe and Asia. Recognized by the World Economic Forum as one of the world's most innovative start-ups, KONUX is committed to transforming railway mobility for a sustainable future.
Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.
NavVis GmbH specializes in indoor spatial intelligence solutions for enterprises, offering advanced tools for mapping and visualizing indoor environments. The company develops the NavVis M6, a mobile mapping system designed for large-scale scanning projects, which captures immersive 360° imagery and point clouds. Its NavVis IndoorViewer integrates these point clouds with detailed images to create digital twins, allowing stakeholders to interact with scanned spaces. The company also provides a software development kit to enhance its offerings. NavVis's solutions support various applications, including CAD/BIM modeling, factory planning, maintenance, and indoor navigation. Its client base includes prominent firms in the automotive, construction, real estate, and insurance sectors. Founded in 2013 and headquartered in Munich, Germany, NavVis also maintains offices in New York and Shanghai.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.
NavVis GmbH specializes in indoor spatial intelligence solutions for enterprises, offering advanced tools for mapping and visualizing indoor environments. The company develops the NavVis M6, a mobile mapping system designed for large-scale scanning projects, which captures immersive 360° imagery and point clouds. Its NavVis IndoorViewer integrates these point clouds with detailed images to create digital twins, allowing stakeholders to interact with scanned spaces. The company also provides a software development kit to enhance its offerings. NavVis's solutions support various applications, including CAD/BIM modeling, factory planning, maintenance, and indoor navigation. Its client base includes prominent firms in the automotive, construction, real estate, and insurance sectors. Founded in 2013 and headquartered in Munich, Germany, NavVis also maintains offices in New York and Shanghai.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.
SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
Private Equity Round in 2012
BRAIN AG specializes in the biologisation of industries, aiming to foster a sustainable bio-based economy. The company develops customized solutions derived from natural biodiversity for various industrial applications. As a pioneer in industrial biotechnology, BRAIN AG utilizes a comprehensive biotechnology toolkit and its proprietary BioArchive, which houses a diverse range of natural compounds. By focusing on customer-specific application needs, BRAIN AG provides innovative bio-based solutions that enhance value from the initial concept through to commercialization and beyond.
SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. The company focuses on kerfless wafering and thinning, offering innovative processes for splitting crystalline materials such as silicon carbide, gallium nitride, and sapphire. SILTECTRA's cold split technology enables efficient processing of crystal materials, making it particularly suitable for applications involving silicon carbide in solar inverters. As a subsidiary of Infineon Technologies AG, SILTECTRA aims to deliver versatile manufacturing solutions that can be applied across various industries and materials.
NFON, based in Munich, Germany, specializes in integrated business communication solutions, primarily focusing on cloud-based telecommunications services for corporate clients. The company's flagship offering, IP Centrex, provides outsourced telephone systems as a comprehensive package, enabling businesses to significantly reduce costs associated with traditional phone systems. NFON's services encompass various areas, including telephony, video calls, screen sharing, and necessary hardware components. Additionally, the company integrates its cloud telephony system with clients' existing systems and workflows, enhancing operational efficiency. NFON also offers products designed to optimize customer contact and prepares companies for the cloud, ensuring they can effectively transition to digital communication solutions. With a high-performance, redundant computer center and over 100 features, NFON caters to organizations of all sizes, promoting streamlined communication and substantial cost savings.
Affiris AG is a Vienna-based company that specializes in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer's disease, Parkinson's disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington's disease. By providing innovative treatment options for neurodegenerative diseases, Affiris strives to enhance the quality of life for patients while offering healthcare professionals a higher level of safety and efficacy compared to traditional therapies.
IDENT Technology AG specializes in technology solutions for e-fields, focusing on near-field communication and gesture-controlled human-machine interfaces. The company offers its SKINPLEX technologies for various applications, including detection, interaction, and identification, primarily through licensing agreements. Key products include SKINPLEX GestIC, designed for gesture detection; the SKINPLEX zeropower sensor system, which facilitates touchless sensing in challenging environments; and the SKINPLEX ultra-low-power proximity system, enabling devices to wake up or power down based on user proximity. Ident Technology's innovations serve a diverse array of industries, such as consumer electronics, gaming, automotive, healthcare, and building management. Founded in 2002, the company is headquartered in Wessling, Germany.
Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
CYNORA GmbH, founded in 2008 and based in Bruchsal, Germany, specializes in the development and manufacture of organic electronics, particularly focusing on organic light-emitting diodes (OLEDs) and organic solar cells. The company is known for its innovative use of Thermally Activated Delayed Fluorescence (TADF) technology, which allows for the efficient conversion of triplet excitons into light, thereby enhancing the performance of OLED devices while reducing power consumption. CYNORA's emitter systems, which are free from iridium, provide high efficiency and stability, addressing the industry's demand for thin, flexible screens with improved image quality. The company collaborates with major manufacturers in Korea and China to showcase the capabilities of its patented materials, contributing significantly to advancements in the AMOLED market. Through their offerings, CYNORA aims to deliver substantial efficiency improvements for display manufacturers, meeting the growing expectations for high-performance OLED products.
AMSilk GmbH, based in Munich, Germany, specializes in producing spider silk proteins and biomaterials for various industrial applications. The company offers a range of products, including BioShield-S1, a non-immunogenic spider silk film used for protective coatings in medical devices, as well as biosteel spider silk fibers. AMSilk also develops over-the-counter wound care products like SanaSilk, designed to protect the skin, and provides spider silk-based solutions for surgical applications. Additionally, the company produces spider silk protein beads and coatings for medical technology, alongside nonwovens for filters, wound dressings, and specialty textiles. Its offerings include both raw materials and semi-finished products such as membranes and films. AMSilk serves multiple sectors, including pharmaceuticals, cosmetics, and technical textiles, and has established a strategic partnership with Gruschwitz Textilwerke AG. The company was founded in 2008.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.
NFON, based in Munich, Germany, specializes in integrated business communication solutions, primarily focusing on cloud-based telecommunications services for corporate clients. The company's flagship offering, IP Centrex, provides outsourced telephone systems as a comprehensive package, enabling businesses to significantly reduce costs associated with traditional phone systems. NFON's services encompass various areas, including telephony, video calls, screen sharing, and necessary hardware components. Additionally, the company integrates its cloud telephony system with clients' existing systems and workflows, enhancing operational efficiency. NFON also offers products designed to optimize customer contact and prepares companies for the cloud, ensuring they can effectively transition to digital communication solutions. With a high-performance, redundant computer center and over 100 features, NFON caters to organizations of all sizes, promoting streamlined communication and substantial cost savings.
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
IDENT Technology AG specializes in technology solutions for e-fields, focusing on near-field communication and gesture-controlled human-machine interfaces. The company offers its SKINPLEX technologies for various applications, including detection, interaction, and identification, primarily through licensing agreements. Key products include SKINPLEX GestIC, designed for gesture detection; the SKINPLEX zeropower sensor system, which facilitates touchless sensing in challenging environments; and the SKINPLEX ultra-low-power proximity system, enabling devices to wake up or power down based on user proximity. Ident Technology's innovations serve a diverse array of industries, such as consumer electronics, gaming, automotive, healthcare, and building management. Founded in 2002, the company is headquartered in Wessling, Germany.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
PDC Biotech GmbH is a biotechnology company based in Vienna, Austria, focused on developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrhea, addressing significant unmet medical needs. Founded in 2008, the company is advancing a pipeline of products that includes antagonists of the prostaglandin F2α (FP) receptor. Key developments include PDC31, a synthetic octapeptide designed as an allosteric modulator of the FP receptor, and the PDC41 Series, a non-intravenous formulation for self-administration in primary dysmenorrhea. PDC Biotech employs various delivery methods, including nasal, sublingual, pulmonary, vaginal, and rectal formulations. The company has secured exclusive worldwide rights to a range of FP receptor antagonists from Theratechnologies Inc., enhancing its potential to impact women's health.
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.
Sovicell is dedicated to providing trusted state-of-the-art ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicology) products and services that enable their customers to rapidly obtain accurate and reproducible pharmacokinetic data about their drug candidates or other test substances.
Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.
Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is renowned for its eChiller, a clean compression refrigeration unit that utilizes pure water as a refrigerant, effectively eliminating the use of harmful fluorinated gases. This innovative technology, known as Bluezero, addresses the growing regulatory demands related to refrigeration while offering sustainable solutions. The eChiller units are designed for diverse cooling needs, including process cooling, machine cooling, and the maintenance of technical equipment and data centers, with capacities ranging from 35 kW to 120 kW. Efficient Energy also provides a comprehensive range of services including consulting, planning, installation, maintenance, and energy efficiency optimization. The company has garnered recognition for its contributions to sustainable technology, receiving multiple awards, including the European Business Award for the Environment and the Red Herring Europe Top 100. Founded in 2006, Efficient Energy continues to lead the way in energy-efficient refrigeration technology.
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.
SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.
Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Sovicell is dedicated to providing trusted state-of-the-art ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicology) products and services that enable their customers to rapidly obtain accurate and reproducible pharmacokinetic data about their drug candidates or other test substances.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.
Private Equity Round in 2005
Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.